Summary
Pretreatment serum lactic acid dehydrogenase (LDH) levels were examined in 82 patients with Ewing’s tumor of bone (23 metastatic and 59 localized). The percentage of patients with increased serum LDH levels was significantly higher in the metastatic group than in the group of patients with localized disease (87 vs. 45%). After treatment with combined therapy, in this latter group the recurrence rate was significantly higher in patients with elevated serum LDH levels at admission than in those with normal serum LDH levels (50 vs. 9%). Of the 16 patients with localized disease who relapsed, 13 (81%) had elevated serum LDH levels at the time of recurrence. These results indicate that in Ewing’s tumor serum LDH levels may serve as useful prognostic markers and could be valuable in monitoring the effectiveness of combined therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bacci G., Picci P., Gitelis S., Borghi A., Campanacci M.: The treatment of localized Ewing’ sarcoma: the experience at the Istituto Ortopedico Rizzoli in 163 cases treated with and without adjuvant chemotherapy. Cancer49, 1561, 1982.
Bacci G.,Picci P.,Gherlinzoni F.,Capanna R.,Putti C.,Mancini I.,Campanacci M.: Localized Ewing’s sarcoma: ten-year experience at the Istituto Ortopedico Rizzoli in 124 cases treated with multimodal therapy.Europ. J. Cancer clin. Oncol. 1984. (In press).
Bergheyer H. W.: Provisional recommendations on IPCC methods for the measurement of catalytic concentrations of enzymes. Clin. Chem.23, 890, 1977.
Bierman H. R., Hill B. R., Reinbrardt L., Emory E.: Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphoma and leukemias. Cancer Res.17, 660, 1957.
Brereton H. D., Simon R., Pomeroy C. C.: Pretreatment serum lactic dehydrogenase predicting metastatic spread in Ewing’s sarcoma. Ann. intern. Med.83, 352, 1975.
Ferraris A. M., Giuntini P., Gaetani G. F.: Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin’s lymphomas. Blood54, 928, 1979.
Gasparini M., Lombardi F.: Adjuvant chemotherapy in Ewing’s sarcoma patient. Rec. Results Cancer Res.80, 120, 1982.
Gehan E. A., Nesbit M. E. Jr.,Burgert E. O. Jr.,Vietti T. J., Tefft M., Perez C. A., Kissane J., Hempel C.: Prognostic factors in children with Ewing’s sarcoma. Nat. Cancer Inst. Monogr.56, 273, 1981.
Glaubiger B. L., MacKuch R., Schwartz J., Levine A. S., Johnnson R. E.: Determination of prognostic factors and their influence on therapeutic results in patients with Ewing’s sarcoma. Cancer45, 2213, 1980.
Goldman A.: Ewing’s sarcoma: treatment with high-dose radiation and adjuvant chemotherapy. Rec. Results Cancer Res.80, 115, 1982.
Haeberg H., Siebaghn A.: Prognostic value of serum lactic dehydrogenase in non-Hodgkin’s lymphoma. Scand. J. Haematol.31, 49, 1983.
Hossfeld D. K., Seeber S., Siemers E., Schmidt C. G., Scherer E.: Early results of combined modality therapy of patients with Ewing’s sarcoma. Rec. Results Cancer Res.80, 124, 1982.
Nesbit M. E. Jr.,Perez C. A., Tefft M., Burgert E. O. Jr.,Vietti T. J., Kissane J., Pritchard D. J., Gehan E. A.: Multimodal therapy for the management of primary, non-metastatic Ewing’s sarcoma of bone: an intergroup study. Nat. Cancer Inst. Monogr.56, 255, 1981.
Pritchard D.J., Dahlin D. C., Dauphine R. T., Taylor W. F., Beabout Y. W.: Ewing’s sarcoma: a clinico-pathological and statistical analysis of patients surviving five years or longer. J. Bone Jt Surg.57A, 10, 1975.
Rosen G., Caparros B., Nirenberg A., Marcove R. C., Huvos A. G., Kosloff C., Lane J., Murphy M. L.: Ewing’s sarcoma: ten-year experience with adjuvant chemotherapy. Cancer47, 2204, 1901.
Schneider R. J., Seibert K., Passe S.: Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer46, 139, 1980.
Wilkinson J. H.: Clinical application of isoenzymes. Clin. Chem.16, 733, 1970.
Wrobleski F., La Due J.: Lactic dehydrogenase activity in blood. Proc. Soc. exp. Biol. (N.Y.)90, 210, 1955.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bacci, G., Capanna, R., Orlandi, M. et al. Prognostic significance of serum lactic acid dehydrogenase in Ewing’s tumor of bone. La Ricerca Clin. Lab. 15, 89–96 (1985). https://doi.org/10.1007/BF03029166
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03029166